Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-151345
Filing Date
2026-04-10
Accepted
2026-04-10 16:30:14
Documents
18
Period of Report
2026-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A clpt-20260410.htm   iXBRL DEF 14A 1427204
2 GRAPHIC img141595704_0.jpg GRAPHIC 4535
3 GRAPHIC img141595704_1.jpg GRAPHIC 4074
4 GRAPHIC img141595704_2.jpg GRAPHIC 214136
5 GRAPHIC img141595704_3.jpg GRAPHIC 208250
6 GRAPHIC img141595704_4.jpg GRAPHIC 152903
7 GRAPHIC img141595704_5.jpg GRAPHIC 150340
  Complete submission text file 0001193125-26-151345.txt   4081804

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clpt-20260410.xsd EX-101.SCH 66561
21 EXTRACTED XBRL INSTANCE DOCUMENT clpt-20260410_htm.xml XML 224296
Mailing Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075
Business Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075 9499006833
ClearPoint Neuro, Inc. (Filer) CIK: 0001285550 (see all company filings)

EIN.: 582394628 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34822 | Film No.: 26855247
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)